The week's good news: August 10, 2023

It wasn't all bad!

A football on a football field
(Image credit: Tetra Images via Getty Images)

1. FDA approves first-ever pill to treat postpartum depression

The Food and Drug Administration on Friday approved a medication called zuranolone for the treatment of postpartum depression, a severe form of depression that some mothers experience after giving birth. There is a treatment that can be given via intravenous injection at a hospital, but zuranolone is the first pill that can be taken at home. "Having access to an oral medication will be a beneficial option for many of these women coping with extreme, and sometimes life-threatening, feelings," Dr. Tiffany R. Farchione, director of the Division of Psychiatry at the FDA's Center for Drug Evaluation and Research, said in a statement. The medication is taken once a day for two weeks. Clinical trials showed that zuranolone improved symptoms like anxiety, difficulty sleeping and social withdrawal as early as three days after taking the first pill, NBC News reported. The trials followed patients for 45 days, and more data is needed to determine if it can be recommended for women who are breastfeeding.

Subscribe to The Week

Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

SUBSCRIBE & SAVE
https://cdn.mos.cms.futurecdn.net/flexiimages/jacafc5zvs1692883516.jpg

Sign up for The Week's Free Newsletters

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

Sign up
Explore More
Catherine Garcia, The Week US

Catherine Garcia has worked as a senior writer at The Week since 2014. Her writing and reporting have appeared in Entertainment Weekly, The New York Times, Wirecutter, NBC News and "The Book of Jezebel," among others. She's a graduate of the University of Redlands and the Columbia University Graduate School of Journalism.